Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Scientific Reports|November 23, 2022
Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironmentHiroaki Sato, Kazuhiro Noma, Toshiaki Ohara, et al.
Cancers|February 6, 2019
A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing StemnessYuki Katsura, Toshiaki Ohara, Kazuhiro Noma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 3, 2004
Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiationTakaomi Ohkawa, Yoshio Naomoto, Munenori Takaoka, et al.
Cancer Gene Therapy|November 29, 2025
p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosisTakeyoshi Nishiyama, Hiroshi Tazawa, Yasuo Nagai, et al.
The Lancet. Gastroenterology & Hepatology|October 16, 2025
Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialHiroya Takeuchi, Ryunosuke Machida, Masahiko Ando, et al.
The British Journal of Surgery|February 20, 2024
Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinomaJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 7, 2026
Clinical diagnostic accuracy and lymph node metastasis patterns in clinical T1bN0M0 esophageal squamous cell carcinoma: a supplementary analysis of JCOG1409Motoo Nomura, Hiroya Takeuchi, Masahiko Ando, et al.
JCI Insight|December 22, 2025
Enhancement of drug delivery through fibroblast activation protein-targeted near-infrared photoimmunotherapySeitaro Nishimura, Kazuhiro Noma, Tasuku Matsumoto, et al.
Journal of Crohn'S & Colitis|December 18, 2022
RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative ColitisKazutaka Takahashi, Kunitoshi Shigeyasu, Yoshitaka Kondo, et al.
Pageof 15